Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL49168 | 0.84 | PTGDR2 (0.44) | PTGDR2SLC6A2SLC6A4SLC6A3DRD2 | |
| SCHEMBL3844188 | 0.80 | NUDT1 (0.49) | PTGDR2TAAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11366023 | 0.80 | PTGDR2 (0.41) | PTGDR2SLC6A2SLC6A4SLC6A3HTR1A | |
| SCHEMBL4825129 | 0.80 | HTR1D (0.43) | PTGDR2SLC6A2SLC6A4SLC6A3DRD2 | |
| SCHEMBL9203359 | 0.80 | PTGDR2 (0.44) | PTGDR2SLC6A2SLC6A4SLC6A3HTR1A | |
| SCHEMBL5544918 | 0.80 | PTGDR2 (0.41) | PTGDR2SLC6A2SLC6A4SLC6A3HTR1A | |
| SCHEMBL11919540 | 0.78 | PTGDR2 (0.54) | PTGDR2NAAA | |
| SCHEMBL3842826 | 0.78 | HTR2A (0.49) | PTGDR2TAAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL27397494 | 0.78 | HTR1D (0.44) | PTGDR2SLC6A2SLC6A4SLC6A3DRD2 | |
| SCHEMBL7496193 | 0.78 | PTGDR2 (0.41) | PTGDR2SLC6A2SLC6A4SLC6A3HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110577837-B | Liquid-crystalline medium | 默克专利股份有限公司 | 2023-05-16 | — | — | CN | disclosed |
| EP-3638657-A1 | DIBENZOFURAN DERIVATIVES AND DIBENZOTHIOPHENE DERIVATIVES | Merck Patent GmbH (DE) | 2020-04-22 | — | — | EP | disclosed |
| EP-2087067-A1 | CYCLOHEXYLENE REACTIVE MESOGENS AND THEIR APPLICATIONS | Merck Patent GmbH (DE) | 2009-08-12 | — | — | EP | disclosed |
| US-7425356-B2 | Chiral compounds | MERCK PATENT GMBH (DE) | 2008-09-16 | — | — | US | disclosed |
| WO-2008061606-A1 | CYCLOHEXYLENE REACTIVE MESOGENS AND THEIR APPLICATIONS | MERCK PATENT GMBH (DE) | 2008-05-29 | — | — | WO | disclosed |
| US-20070229732-A1 | CHIRAL COMPOUNDS | TAUGERBECK ANDREAS | 2007-10-04 | — | — | US | disclosed |
| EP-0491901-A1 | ELECTRO-OPTICAL SYSTEM | MERCK PATENT GmbH (DE) | 1992-07-01 | — | — | EP | disclosed |
| EP-0482157-A1 | 1,3-DIOXANE DERIVATES AND LIQUID CRYSTAL MEDIUM | MERCK PATENT GmbH (DE) | 1992-04-29 | — | — | EP | disclosed |
| EP-0480008-A1 | PHENYL CYCLOHEXANES AND LIQUID CRYSTAL MEDIUM. | MERCK PATENT GMBH (DE) | 1992-04-15 | — | — | EP | disclosed |
| EP-0476103-A1 | PHENYL CYCLOHEXANES AND LIQUID CRYSTAL MEDIUM | MERCK PATENT GmbH (DE) | 1992-03-25 | — | — | EP | disclosed |
| EP-0438574-A1 | 2,5-DISUBSTITUTED HETEROCYCLES AND MESOMORPHOUS MEDIUM. | MERCK PATENT GMBH (DE) | 1991-07-31 | — | — | EP | disclosed |
| EP-0429558-A1 | DIPHENYLYLETHANES AND LIQUID CRYSTALLINE PHASE. | MERCK PATENT GMBH (DE) | 1991-06-05 | — | — | EP | disclosed |
| EP-0427829-A1 | TRIFLUOROTOLUOL COMPOUNDS AND LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GmbH (DE) | 1991-05-22 | — | — | EP | disclosed |
| EP-0418362-A1 | TRIFLUOROMETHYLCYCLOHEXANE DERIVATIVES. | MERCK PATENT GMBH (DE) | 1991-03-27 | — | — | EP | disclosed |
| EP-0400068-A1 | DERIVATIVES OF 2,3-DIFLUOROPHENOL | MERCK PATENT GmbH (DE) | 1990-12-05 | — | — | EP | disclosed |
| EP-0364538-A1 | DIFLUOROBENZOL DERIVATIVES. | MERCK PATENT GMBH (DE) | 1990-04-25 | — | — | EP | disclosed |
| EP-0358741-A1 | DERIVATIVES OF 2,3-DIFLUOROBENZOIC ACID. | MERCK PATENT GMBH (DE) | 1990-03-21 | — | — | EP | disclosed |
| WO-1989008688-A1 | DERIVATIVES OF 2,3-DIFLUOROBENZOIC ACID | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1989-09-21 | — | — | WO | disclosed |
| WO-1989008633-A1 | DIFLUOROBENZOL DERIVATIVES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1989-09-21 | — | — | WO | disclosed |
| WO-1989008632-A1 | DERIVATIVES OF 2,3-DIFLUOROPHENOL | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1989-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070229732-A1 | CHIRAL COMPOUNDS | F12, F2, C1S | PTGDR2 239/4885TAAR1 818/4885SLC6A2 1903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.